APO Research
Talk to an analyst

APO RESEARCH · REPORT

Afatinib Maleate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Afatinib Maleate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025182 pages

Choose your research edition.

Industry ResearchAfatinib Maleate Tablets Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Afatinib Maleate Tablets Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Afatinib Maleate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Afatinib Maleate Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Afatinib Maleate Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Afatinib Maleate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Afatinib Maleate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Afatinib Maleate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Afatinib Maleate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Afatinib Maleate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Afatinib Maleate Tablets include Yangtze River Pharm, Qingfeng Medicine Group, Qilu Pharmaceutical, Beacon Pharmaceuticals, Kelun－Kazpharm, Hansoh Pharmaceuticak, Chia Tai-Tianqing and Boehringer Ingelheim International GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Afatinib Maleate Tablets market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Afatinib Maleate Tablets and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Afatinib Maleate Tablets revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Afatinib Maleate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Afatinib Maleate Tablets Segment by Company

Yangtze River Pharm

Qingfeng Medicine Group

Qilu Pharmaceutical

Beacon Pharmaceuticals

Kelun－Kazpharm

Hansoh Pharmaceuticak

Chia Tai-Tianqing

Boehringer Ingelheim International GmbH

Afatinib Maleate Tablets Segment by Type

50mg

40mg

30mg

20mg

Afatinib Maleate Tablets Segment by Application

Hospital

Clinic

Others

Afatinib Maleate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Afatinib Maleate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Afatinib Maleate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Afatinib Maleate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Afatinib Maleate Tablets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Afatinib Maleate Tablets industry.

Chapter 3: Detailed analysis of Afatinib Maleate Tablets companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Afatinib Maleate Tabletsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Afatinib Maleate Tablets Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 50mg Table 3. Key Players of 40mg Table 4. Key Players of 30mg Table 3. Key Players of 20mg Table 4. Global Afatinib Maleate Tablets Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Others Table 8. Global Afatinib Maleate Tablets Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Afatinib Maleate Tablets Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Afatinib Maleate Tablets Market Share by Region (2021-2026) Table 11. Global Afatinib Maleate Tablets Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Afatinib Maleate Tablets Market Share by Region (2027-2032) Table 13. Afatinib Maleate Tablets Industry Trends Table 14. Afatinib Maleate Tablets Industry Drivers Table 15. Afatinib Maleate Tablets Industry Opportunities and Challenges Table 16. Afatinib Maleate Tablets Industry Restraints Table 17. Global Afatinib Maleate Tablets Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Afatinib Maleate Tablets Revenue Market Share by Company (2021-2026) Table 19. Global Afatinib Maleate Tablets Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Afatinib Maleate Tablets Key Company Head Office and Area Served Table 21. Global Afatinib Maleate Tablets Company, Product Type & Application Table 22. Global Afatinib Maleate Tablets Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Afatinib Maleate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Afatinib Maleate Tablets Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Afatinib Maleate Tablets Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Afatinib Maleate Tablets Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Afatinib Maleate Tablets Revenue Market Share by Type (2021-2026) Table 29. Global Afatinib Maleate Tablets Revenue Market Share by Type (2027-2032) Table 30. Global Afatinib Maleate Tablets Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Afatinib Maleate Tablets Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Afatinib Maleate Tablets Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Afatinib Maleate Tablets Revenue Market Share by Application (2021-2026) Table 34. Global Afatinib Maleate Tablets Revenue Market Share by Application (2027-2032) Table 35. Yangtze River Pharm Company Information Table 36. Yangtze River Pharm Business Overview Table 37. Yangtze River Pharm Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Yangtze River Pharm Afatinib Maleate Tablets Product Portfolio Table 39. Yangtze River Pharm Recent Development Table 40. Qingfeng Medicine Group Company Information Table 41. Qingfeng Medicine Group Business Overview Table 42. Qingfeng Medicine Group Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Qingfeng Medicine Group Afatinib Maleate Tablets Product Portfolio Table 44. Qingfeng Medicine Group Recent Development Table 45. Qilu Pharmaceutical Company Information Table 46. Qilu Pharmaceutical Business Overview Table 47. Qilu Pharmaceutical Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Qilu Pharmaceutical Afatinib Maleate Tablets Product Portfolio Table 49. Qilu Pharmaceutical Recent Development Table 50. Beacon Pharmaceuticals Company Information Table 51. Beacon Pharmaceuticals Business Overview Table 52. Beacon Pharmaceuticals Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Beacon Pharmaceuticals Afatinib Maleate Tablets Product Portfolio Table 54. Beacon Pharmaceuticals Recent Development Table 55. Kelun－Kazpharm Company Information Table 56. Kelun－Kazpharm Business Overview Table 57. Kelun－Kazpharm Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Kelun－Kazpharm Afatinib Maleate Tablets Product Portfolio Table 59. Kelun－Kazpharm Recent Development Table 60. Hansoh Pharmaceuticak Company Information Table 61. Hansoh Pharmaceuticak Business Overview Table 62. Hansoh Pharmaceuticak Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Hansoh Pharmaceuticak Afatinib Maleate Tablets Product Portfolio Table 64. Hansoh Pharmaceuticak Recent Development Table 65. Chia Tai-Tianqing Company Information Table 66. Chia Tai-Tianqing Business Overview Table 67. Chia Tai-Tianqing Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Chia Tai-Tianqing Afatinib Maleate Tablets Product Portfolio Table 69. Chia Tai-Tianqing Recent Development Table 70. Boehringer Ingelheim International GmbH Company Information Table 71. Boehringer Ingelheim International GmbH Business Overview Table 72. Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Product Portfolio Table 74. Boehringer Ingelheim International GmbH Recent Development Table 75. North America Afatinib Maleate Tablets Market Size by Type (2021-2026) & (US$ Million) Table 76. North America Afatinib Maleate Tablets Market Size by Type (2027-2032) & (US$ Million) Table 77. North America Afatinib Maleate Tablets Market Size by Application (2021-2026) & (US$ Million) Table 78. North America Afatinib Maleate Tablets Market Size by Application (2027-2032) & (US$ Million) Table 79. North America Afatinib Maleate Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Afatinib Maleate Tablets Market Size by Country (2021-2026) Table 81. North America Afatinib Maleate Tablets Market Size by Country (2027-2032) Table 82. Europe Afatinib Maleate Tablets Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe Afatinib Maleate Tablets Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe Afatinib Maleate Tablets Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe Afatinib Maleate Tablets Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe Afatinib Maleate Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Afatinib Maleate Tablets Market Size by Country (2021-2026) Table 88. Europe Afatinib Maleate Tablets Market Size by Country (2027-2032) Table 89. China Afatinib Maleate Tablets Market Size by Type (2021-2026) & (US$ Million) Table 90. China Afatinib Maleate Tablets Market Size by Type (2027-2032) & (US$ Million) Table 91. China Afatinib Maleate Tablets Market Size by Application (2021-2026) & (US$ Million) Table 92. China Afatinib Maleate Tablets Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Afatinib Maleate Tablets Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia Afatinib Maleate Tablets Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia Afatinib Maleate Tablets Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia Afatinib Maleate Tablets Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia Afatinib Maleate Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Afatinib Maleate Tablets Market Size by Country (2021-2026) Table 99. Asia Afatinib Maleate Tablets Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Afatinib Maleate Tablets Product Image Figure 2. Global Afatinib Maleate Tablets Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Afatinib Maleate Tablets Market Share by Type: 2025 VS 2032 Figure 4. 50mg Image Figure 5. 40mg Image Figure 6. 30mg Image Figure 7. 20mg Image Figure 8. Global Afatinib Maleate Tablets Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Afatinib Maleate Tablets Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Afatinib Maleate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 15. Global Afatinib Maleate Tablets Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Afatinib Maleate Tablets Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Afatinib Maleate Tablets Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Afatinib Maleate Tablets Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Afatinib Maleate Tablets Revenue Market Share by Type (2021-2032) Figure 22. Global Afatinib Maleate Tablets Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Afatinib Maleate Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 25. North America Afatinib Maleate Tablets Market Share by Type (2021-2032) Figure 26. North America Afatinib Maleate Tablets Market Share by Application (2021-2032) Figure 27. North America Afatinib Maleate Tablets Market Share by Country (2021-2032) Figure 28. United States Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 29. Canada Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 31. Europe Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 32. Europe Afatinib Maleate Tablets Market Share by Type (2021-2032) Figure 33. Europe Afatinib Maleate Tablets Market Share by Application (2021-2032) Figure 34. Europe Afatinib Maleate Tablets Market Share by Country (2021-2032) Figure 35. Germany Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 36. France Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 38. Italy Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 39. Russia Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 41. China Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 42. China Afatinib Maleate Tablets Market Share by Type (2021-2032) Figure 43. China Afatinib Maleate Tablets Market Share by Application (2021-2032) Figure 44. Asia Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 45. Asia Afatinib Maleate Tablets Market Share by Type (2021-2032) Figure 46. Asia Afatinib Maleate Tablets Market Share by Application (2021-2032) Figure 47. Asia Afatinib Maleate Tablets Market Share by Country (2021-2032) Figure 48. Japan Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 52. India Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 53. Australia Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Afatinib Maleate Tablets Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Afatinib Maleate Tablets Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Afatinib Maleate Tablets Market Share by Country (2021-2032) Figure 58. Brazil Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 63. UAE Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 65. Chile Afatinib Maleate Tablets Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 40mg
  • 30mg
  • 20mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Yangtze River Pharm
  • Qingfeng Medicine Group
  • Qilu Pharmaceutical
  • Beacon Pharmaceuticals
  • Kelun－Kazpharm
  • Hansoh Pharmaceuticak
  • Chia Tai-Tianqing
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Afatinib Maleate Tablets Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 50mg
  5. 1.2.3 40mg
  6. 1.2.4 30mg
  7. 1.2.5 20mg
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Afatinib Maleate Tablets Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Afatinib Maleate Tablets Growth Trends by Region
  15. 1.5.1 Global Afatinib Maleate Tablets Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Afatinib Maleate Tablets Market Size by Region (2021-2026)
  17. 1.5.3 Afatinib Maleate Tablets Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Afatinib Maleate Tablets Market Dynamics
  1. 2.1 Afatinib Maleate Tablets Industry Trends
  2. 2.2 Afatinib Maleate Tablets Industry Drivers
  3. 2.3 Afatinib Maleate Tablets Industry Opportunities and Challenges
  4. 2.4 Afatinib Maleate Tablets Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Afatinib Maleate Tablets Revenue by Company (2021-2026)
  2. 3.2 Global Afatinib Maleate Tablets Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Afatinib Maleate Tablets Key Company Head office and Area Served
  4. 3.4 Global Afatinib Maleate Tablets Company, Product Type & Application
  5. 3.5 Global Afatinib Maleate Tablets Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Afatinib Maleate Tablets Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Afatinib Maleate Tablets Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Afatinib Maleate Tablets Tier 1, Tier 2, and Tier 3
4 Afatinib Maleate Tablets Market by Type
  1. 4.1 Global Afatinib Maleate Tablets Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Afatinib Maleate Tablets Market Size by Type (2021-2032)
  3. 4.3 Global Afatinib Maleate Tablets Market Size Share by Type (2021-2032)
5 Afatinib Maleate Tablets Market by Application
  1. 5.1 Global Afatinib Maleate Tablets Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Afatinib Maleate Tablets Market Size by Application (2021-2032)
  3. 5.3 Global Afatinib Maleate Tablets Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Yangtze River Pharm
  2. 6.1.1 Yangtze River Pharm Company Information
  3. 6.1.2 Yangtze River Pharm Business Overview
  4. 6.1.3 Yangtze River Pharm Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Yangtze River Pharm Afatinib Maleate Tablets Product Portfolio
  6. 6.1.5 Yangtze River Pharm Recent Developments
  7. 6.2 Qingfeng Medicine Group
  8. 6.2.1 Qingfeng Medicine Group Company Information
  9. 6.2.2 Qingfeng Medicine Group Business Overview
  10. 6.2.3 Qingfeng Medicine Group Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Qingfeng Medicine Group Afatinib Maleate Tablets Product Portfolio
  12. 6.2.5 Qingfeng Medicine Group Recent Developments
  13. 6.3 Qilu Pharmaceutical
  14. 6.3.1 Qilu Pharmaceutical Company Information
  15. 6.3.2 Qilu Pharmaceutical Business Overview
  16. 6.3.3 Qilu Pharmaceutical Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Qilu Pharmaceutical Afatinib Maleate Tablets Product Portfolio
  18. 6.3.5 Qilu Pharmaceutical Recent Developments
  19. 6.4 Beacon Pharmaceuticals
  20. 6.4.1 Beacon Pharmaceuticals Company Information
  21. 6.4.2 Beacon Pharmaceuticals Business Overview
  22. 6.4.3 Beacon Pharmaceuticals Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Beacon Pharmaceuticals Afatinib Maleate Tablets Product Portfolio
  24. 6.4.5 Beacon Pharmaceuticals Recent Developments
  25. 6.5 Kelun－Kazpharm
  26. 6.5.1 Kelun－Kazpharm Company Information
  27. 6.5.2 Kelun－Kazpharm Business Overview
  28. 6.5.3 Kelun－Kazpharm Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Kelun－Kazpharm Afatinib Maleate Tablets Product Portfolio
  30. 6.5.5 Kelun－Kazpharm Recent Developments
  31. 6.6 Hansoh Pharmaceuticak
  32. 6.6.1 Hansoh Pharmaceuticak Company Information
  33. 6.6.2 Hansoh Pharmaceuticak Business Overview
  34. 6.6.3 Hansoh Pharmaceuticak Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Hansoh Pharmaceuticak Afatinib Maleate Tablets Product Portfolio
  36. 6.6.5 Hansoh Pharmaceuticak Recent Developments
  37. 6.7 Chia Tai-Tianqing
  38. 6.7.1 Chia Tai-Tianqing Company Information
  39. 6.7.2 Chia Tai-Tianqing Business Overview
  40. 6.7.3 Chia Tai-Tianqing Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Chia Tai-Tianqing Afatinib Maleate Tablets Product Portfolio
  42. 6.7.5 Chia Tai-Tianqing Recent Developments
  43. 6.8 Boehringer Ingelheim International GmbH
  44. 6.8.1 Boehringer Ingelheim International GmbH Company Information
  45. 6.8.2 Boehringer Ingelheim International GmbH Business Overview
  46. 6.8.3 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Product Portfolio
  48. 6.8.5 Boehringer Ingelheim International GmbH Recent Developments
7 North America
  1. 7.1 North America Afatinib Maleate Tablets Market Size (2021-2032)
  2. 7.2 North America Afatinib Maleate Tablets Market Size by Type
  3. 7.2.1 North America Afatinib Maleate Tablets Market Size by Type (2021-2026)
  4. 7.2.2 North America Afatinib Maleate Tablets Market Size by Type (2027-2032)
  5. 7.2.3 North America Afatinib Maleate Tablets Market Share by Type (2021-2032)
  6. 7.3 North America Afatinib Maleate Tablets Market Size by Application
  7. 7.3.1 North America Afatinib Maleate Tablets Market Size by Application (2021-2026)
  8. 7.3.2 North America Afatinib Maleate Tablets Market Size by Application (2027-2032)
  9. 7.3.3 North America Afatinib Maleate Tablets Market Share by Application (2021-2032)
  10. 7.4 North America Afatinib Maleate Tablets Market Size by Country
  11. 7.4.1 North America Afatinib Maleate Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Afatinib Maleate Tablets Market Size by Country (2021-2026)
  13. 7.4.3 North America Afatinib Maleate Tablets Market Size by Country (2027-2032)
  14. 7.4.4 North America Afatinib Maleate Tablets Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Afatinib Maleate Tablets Market Size (2021-2032)
  2. 8.2 Europe Afatinib Maleate Tablets Market Size by Type
  3. 8.2.1 Europe Afatinib Maleate Tablets Market Size by Type (2021-2026)
  4. 8.2.2 Europe Afatinib Maleate Tablets Market Size by Type (2027-2032)
  5. 8.2.3 Europe Afatinib Maleate Tablets Market Share by Type (2021-2032)
  6. 8.3 Europe Afatinib Maleate Tablets Market Size by Application
  7. 8.3.1 Europe Afatinib Maleate Tablets Market Size by Application (2021-2026)
  8. 8.3.2 Europe Afatinib Maleate Tablets Market Size by Application (2027-2032)
  9. 8.3.3 Europe Afatinib Maleate Tablets Market Share by Application (2021-2032)
  10. 8.4 Europe Afatinib Maleate Tablets Market Size by Country
  11. 8.4.1 Europe Afatinib Maleate Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Afatinib Maleate Tablets Market Size by Country (2021-2026)
  13. 8.4.3 Europe Afatinib Maleate Tablets Market Size by Country (2027-2032)
  14. 8.4.4 Europe Afatinib Maleate Tablets Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Afatinib Maleate Tablets Market Size (2021-2032)
  2. 9.2 China Afatinib Maleate Tablets Market Size by Type
  3. 9.2.1 China Afatinib Maleate Tablets Market Size by Type (2021-2026)
  4. 9.2.2 China Afatinib Maleate Tablets Market Size by Type (2027-2032)
  5. 9.2.3 China Afatinib Maleate Tablets Market Share by Type (2021-2032)
  6. 9.3 China Afatinib Maleate Tablets Market Size by Application
  7. 9.3.1 China Afatinib Maleate Tablets Market Size by Application (2021-2026)
  8. 9.3.2 China Afatinib Maleate Tablets Market Size by Application (2027-2032)
  9. 9.3.3 China Afatinib Maleate Tablets Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Afatinib Maleate Tablets Market Size (2021-2032)
  2. 10.2 Asia Afatinib Maleate Tablets Market Size by Type
  3. 10.2.1 Asia Afatinib Maleate Tablets Market Size by Type (2021-2026)
  4. 10.2.2 Asia Afatinib Maleate Tablets Market Size by Type (2027-2032)
  5. 10.2.3 Asia Afatinib Maleate Tablets Market Share by Type (2021-2032)
  6. 10.3 Asia Afatinib Maleate Tablets Market Size by Application
  7. 10.3.1 Asia Afatinib Maleate Tablets Market Size by Application (2021-2026)
  8. 10.3.2 Asia Afatinib Maleate Tablets Market Size by Application (2027-2032)
  9. 10.3.3 Asia Afatinib Maleate Tablets Market Share by Application (2021-2032)
  10. 10.4 Asia Afatinib Maleate Tablets Market Size by Country
  11. 10.4.1 Asia Afatinib Maleate Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Afatinib Maleate Tablets Market Size by Country (2021-2026)
  13. 10.4.3 Asia Afatinib Maleate Tablets Market Size by Country (2027-2032)
  14. 10.4.4 Asia Afatinib Maleate Tablets Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Afatinib Maleate Tablets Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Afatinib Maleate Tablets Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Afatinib Maleate Tablets Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Afatinib Maleate Tablets Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Afatinib Maleate Tablets Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst